REG - CVS Group plc - Long Term Incentive Plan Awards & PDMR Dealing
RNS Number : 7056ECVS Group plc09 November 2020CVS Group Plc
("CVS" or the "Company")
Long Term Incentive Plan Awards & PDMR Dealing
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that it has concluded its annual grant of option awards over a total of 136,485 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2020 ("LTIP 14") (the "Options"). The Option awards were made to certain Directors as detailed below, with the balance being issued to certain other employees.
Options awarded to Directors
Number of
Name Role Ordinary SharesRichard Fairman Chief Executive Officer 41,030
Ben Jacklin Chief Operating Officer 24,618
Robin Alfonso Chief Financial Officer 13,540
The awards will vest over three years, subject to certain performance criteria, relating to earnings per share growth and total shareholder return over the three-year period between 1 July 2020 and 30 June 2023, being satisfied.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Richard Fairman
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
Grant of options under LTIP 14
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Exercise price of 0.2p
41,030
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
6 October 2020
f)
Place of the transaction
Off market
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ben Jacklin
2
Reason for the notification
a)
Position/status
Chief Operating Officer
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
Grant of options under LTIP 14
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Exercise price of 0.2p
24,618
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
6 October 2020
f)
Place of the transaction
Off market
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Robin Alfonso
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
Grant of options under LTIP 14
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Exercise price of 0.2p
13,540
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
6 October 2020
f)
Place of the transaction
Off market
Contacts:
CVS Group Plc Tel: 01379 644288
Richard Fairman, Chief Executive
Juliet Dearlove, Company Secretary
N+1 Singer (Nominated Adviser and Broker) Tel: 020 7496 3000
Aubrey Powell/ Jen Boorer / Ben Farrow (Corporate Finance)
Rachel Hayes (Corporate Broking)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHEADFNEDEEFFA
Recent news on CVS
See all newsREG - CVS Group plc - Standard form for notification of major holdings
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - Disposal of Crematorium Operations
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - PDMR Dealing
Announcement